CNE000001DL5
CNE000001DL5
ZHEJIANG HUAHAI PHARMACEUTICAL
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 26.13B EUR | 21.56B EUR | 24.05B EUR | 25.41B EUR |
Enterprise Value | 32.52B EUR | 27.88B EUR | 30.82B EUR | 31.94B EUR |
Valuation Multiples | ||||
Trailing P/E | 41.55x | 32.82x | 59.77x | 85.98x |
Forward P/E | 52.88x | -- | -- | -- |
Price to Sales | 2.91x | 3.04x | 3.61x | 3.8x |
Price to Book | 2.73x | 2.2x | 2.44x | 2.69x |
EV/Revenue | 3.62x | 3.93x | 4.63x | 4.77x |
EV/EBITDA | 18.23x | 25.18x | 35.88x | 40.74x |
Price to FCF (P/FCF) | -- | 125.3x | -- | -- |
EV/FCF | -- | 162.03x | -- | -- |
FCF Yield | -1.39% | 0.8% | -1.92% | -2.38% |